Log In
Print this Print this

Posidur, bupivacaine (formerly Optesia)

  Manage Alerts
Collapse Summary General Information
Company Durect Corp.
DescriptionInjectable biodegradable gel for sustained-release delivery of bupivacaine
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationPain
Indication DetailsTreat postoperative pain; Treat postoperative pain following inguinal hernia; Treat postoperative pain following shoulder surgery
Regulatory Designation U.S. - Undisclosed Review (Treat postoperative pain)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today